CTMX
CytomX Therapeutics, Inc.Company with tickers: CTMX
CIK
1501989
CUSIP
23284F105
Shares Outstanding
216,177,309
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-17 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2026-03-17 | McCarthy Sean A. | Director, CEO | Sell | 118,969 |
| 2026-03-17 | Chu Yu-Waye | Chief Medical Officer | Sell | 21,279 |
| 2026-03-17 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | 31,492 |
| 2026-03-17 | Ogden Christopher | Chief Financial Officer | Sell | 19,323 |
| 2026-02-02 | Lester Rachael | Chief Business Officer | Award | 50,000 |
| 2026-02-02 | Lester Rachael | Chief Business Officer | Award | 50,000 |
| 2026-02-02 | Lester Rachael | Chief Business Officer | Award | 20,000 |
| 2026-02-02 | Chu Yu-Waye | Chief Medical Officer | Award | 75,000 |
| 2026-02-02 | Chu Yu-Waye | Chief Medical Officer | Award | 300,000 |
| 2026-02-02 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 250,000 |
| 2026-02-02 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 60,000 |
| 2026-02-02 | Ogden Christopher | Chief Financial Officer | Award | 90,000 |
| 2026-02-02 | Ogden Christopher | Chief Financial Officer | Award | 325,000 |
| 2026-02-02 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2026-02-02 | McCarthy Sean A. | Director, CEO | Award | 210,000 |
| 2026-02-02 | McCarthy Sean A. | Director, CEO | Award | 980,000 |
| 2025-11-06 | McCarthy Sean A. | Director, CEO | Sell | 101,793 |
| 2025-11-06 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2025-10-20 | Lester Rachael | Chief Business Officer | Award | 650,000 |
| 2025-10-20 | Lester Rachael | Chief Business Officer | Other | 0 |
| 2025-09-26 | Ogden Christopher | Chief Financial Officer | Award | 39,150 |
| 2025-09-26 | Ogden Christopher | Chief Financial Officer | Award | 78,250 |
| 2025-09-26 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 18,150 |
| 2025-09-26 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 36,300 |
| 2025-09-26 | McCarthy Sean A. | Director, CEO | Award | 285,000 |
| 2025-09-26 | McCarthy Sean A. | Director, CEO | Award | 570,000 |
| 2025-09-26 | Chu Yu-Waye | Chief Medical Officer | Award | 87,500 |
| 2025-09-26 | Chu Yu-Waye | Chief Medical Officer | Award | 43,750 |
| 2025-06-16 | Ogden Christopher | Chief Financial Officer | Sell | 10,614 |
| 2025-06-16 | McCarthy Sean A. | Director, CEO | Sell | 55,511 |
| 2025-06-16 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | 13,884 |
| 2025-06-13 | Ogden Christopher | Chief Financial Officer | Convert | 37,500 |
| 2025-06-13 | Ogden Christopher | Chief Financial Officer | Convert | 37,500 |
| 2025-06-13 | Ogden Christopher | Chief Financial Officer | Sell | 1,641 |
| 2025-06-13 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2025-06-13 | BELVIN MARCIA | SVP, Chief Scientific Officer | Convert | 37,500 |
| 2025-06-13 | BELVIN MARCIA | SVP, Chief Scientific Officer | Convert | 37,500 |
| 2025-06-13 | McCarthy Sean A. | Director, CEO | Convert | 150,000 |
| 2025-06-13 | McCarthy Sean A. | Director, CEO | Convert | 150,000 |
| 2025-06-11 | Gilbert Halley E | Director | Award | 38,000 |
| 2025-06-11 | Ashworth Alan | Director | Award | 38,000 |
| 2025-06-11 | Meyers James R | Director | Award | 38,000 |
| 2025-06-11 | Su Zhen | Director | Award | 38,000 |
| 2025-06-11 | Young Matthew P. | Director | Award | 38,000 |
| 2025-06-11 | Mohindru Mani | Director | Award | 38,000 |
| 2025-06-11 | Jones Elaine V | Director | Award | 38,000 |
| 2025-03-18 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2025-03-18 | McCarthy Sean A. | Director, CEO | Sell | 37,656 |
| 2025-03-18 | Chu Yu-Waye | Chief Medical Officer | Sell | 4,025 |
| 2025-03-18 | ROWLAND LLOYD A | General Counsel | Sell | 10,203 |
| 2025-03-18 | Ogden Christopher | Chief Financial Officer | Sell | 8,551 |
| 2025-03-18 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | 19,512 |
| 2025-02-04 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 30,000 |
| 2025-02-04 | BELVIN MARCIA | SVP, Chief Scientific Officer | Award | 140,000 |
| 2025-02-04 | McCarthy Sean A. | Director, CEO | Award | 800,000 |
| 2025-02-04 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2025-02-04 | McCarthy Sean A. | Director, CEO | Award | 180,000 |
| 2025-02-04 | Ogden Christopher | Chief Financial Officer | Award | 225,000 |
| 2025-02-04 | Ogden Christopher | Chief Financial Officer | Award | 44,000 |
| 2025-02-04 | Chu Yu-Waye | Chief Medical Officer | Award | 238,000 |
| 2025-02-04 | Chu Yu-Waye | Chief Medical Officer | Award | 56,000 |
| 2024-08-20 | Landau Jeffrey B | Chief Business Officer | Convert | 11,250 |
| 2024-08-20 | Landau Jeffrey B | Chief Business Officer | Other | 4,500 |
| 2024-08-20 | Landau Jeffrey B | Chief Business Officer | Convert | 11,250 |
| 2024-08-20 | Landau Jeffrey B | Chief Business Officer | Sell | 4,181 |
| 2024-08-20 | ROWLAND LLOYD A | General Counsel | Convert | 11,250 |
| 2024-08-20 | ROWLAND LLOYD A | General Counsel | Convert | 11,250 |
| 2024-08-20 | ROWLAND LLOYD A | General Counsel | Sell | 4,181 |
| 2024-08-20 | McCarthy Sean A. | Director, CEO | Convert | 37,500 |
| 2024-08-20 | McCarthy Sean A. | Director, CEO | Sell | 13,898 |
| 2024-08-20 | McCarthy Sean A. | Director, CEO | Convert | 37,500 |
| 2024-08-20 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2024-08-20 | BELVIN MARCIA | SVP, Chief Scientific Officer | Convert | 11,250 |
| 2024-08-20 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | 4,181 |
| 2024-08-20 | BELVIN MARCIA | SVP, Chief Scientific Officer | Convert | 11,250 |
| 2024-08-20 | Ogden Christopher | Chief Financial Officer | Convert | 6,875 |
| 2024-08-20 | Ogden Christopher | Chief Financial Officer | Convert | 6,875 |
| 2024-08-20 | Ogden Christopher | Chief Financial Officer | Sell | 1,984 |
| 2024-06-12 | Ogden Christopher | Chief Financial Officer | Award | 75,000 |
| 2024-06-12 | Ogden Christopher | Chief Financial Officer | Award | 17,500 |
| 2024-05-15 | Meyers James R | Director | Award | 38,000 |
| 2024-05-15 | Gilbert Halley E | Director | Award | 38,000 |
| 2024-05-15 | Su Zhen | Director | Award | 38,000 |
| 2024-05-15 | Ashworth Alan | Director | Award | 38,000 |
| 2024-05-15 | Young Matthew P. | Director | Award | 38,000 |
| 2024-05-15 | Mohindru Mani | Director | Award | 38,000 |
| 2024-05-15 | Jones Elaine V | Director | Award | 38,000 |
| 2024-03-26 | McCarthy Sean A. | Director, CEO | Convert | 109,768 |
| 2024-03-26 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2024-03-26 | McCarthy Sean A. | Director, CEO | Convert | 109,768 |
| 2024-03-20 | Su Zhen | Director | Award | 76,000 |
| 2024-03-20 | Su Zhen | Director | Other | 0 |
| 2024-03-19 | Landau Jeffrey B | Chief Business Officer | Sell | 6,562 |
| 2024-03-19 | Landau Jeffrey B | Chief Business Officer | Other | 4,500 |
| 2024-03-19 | ROWLAND LLOYD A | General Counsel | Sell | 5,268 |
| 2024-03-19 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | 12,795 |
| 2024-03-19 | McCarthy Sean A. | Director, CEO | Sell | 20,223 |
| 2024-03-19 | McCarthy Sean A. | Director, CEO | Other | 93,158 |
| 2024-03-19 | Ogden Christopher | Chief Financial Officer | Sell | 2,971 |